The structural plasticity of an essential toxin-secretion system in Mycobacterium tuberculosis

Support this project
Status: In-progress
Year: 2021
Funded: $110,000
Grant Type: Major Project Grant

The growing resistance of microbes to medicines used to prevent and treat infections is a global health threat. The pathogenic bacterium Mycobacterium tuberculosis already kills >1 million people per year and is increasingly developing resistance to the few available treatments we have. One way that M. tuberculosis survives in humans is by secreting a toxin that kills immune cells. This toxin relies on proper and efficient secretion at the right time for effective killing, therefore making the machinery that secretes it a good target for drug discovery efforts. This project seeks to understand the role of a crucial component of the system that exports this toxin from the bacteria, by uncovering how this component is structured and assembled. The understanding of this system will give us the knowledge that may help to develop the urgently needed new treatments for tackling this global pandemic.

Researcher // Dr Timothy Allison – University of Canterbury

More About Dr Timothy Allison
cases diagnosed in New Zealand each year
0 %
of cases diagnosed in NZ born patients are Maori

Stay in touch with CMRF

// Get all the latest news and insights to your inbox